NCT01025635View on ClinicalTrials.gov

Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea

PHASE2CompletedINTERVENTIONAL
Enrollment

401

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Papulopustular Rosacea
Interventions
DRUG

Azelaic acid foam 15%

Applied topically twice daily for 12 weeks

DRUG

Vehicle foam

Applied topically twice daily for 12 weeks

Trial Locations (20)

27103

Winston-Salem

27262

High Point

28401

Wilmington

29681

Simpsonville

33027

Miramar

33175

Miami

35209

Birmingham

35233

Birmingham

37215

Nashville

37922

Knoxville

53719

Madison

68144

Omaha

75093

Plano

78759

Austin

84124

Salt Lake City

87106

Albuquerque

90404

Santa Monica

94538

Fremont

97210

Portland

02919

Johnston

Sponsors

Lead Sponsor

LEO Pharma

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

LEO Pharma

INDUSTRY